Artículos de revistas
Methylpiperidinium iodides as novel antagonists for α7 nicotinic acetylcholine receptors
Fecha
2018Registro en:
Frontiers in Pharmacology, Volumen 9, Issue JUL, 2018,
16639812
10.3389/fphar.2018.00744
Autor
López, Jhon J.
García-Colunga, Jesús
Pérez, Edwin G.
Fierro, Angélica
Institución
Resumen
© 2018 López, García-Colunga, Pérez and Fierro. The α7 nicotinic acetylcholine receptor (nAChR) is expressed in neuronal and non-neuronal cells and is involved in several physiopathological processes, and is thus an important drug target. We have designed and synthesized novel piperidine derivatives as α7 nAChR antagonists. Thus, we describe here a new series of 1-[2-(4-alkoxy-phenoxy-ethyl)]piperidines and 1-[2-(4-alkyloxy-phenoxy-ethyl)]-1-methylpiperidinium iodides (compounds 11a-11c and 12a-12c), and their actions on α7 nAChRs. The pharmacological activity of these compounds was studied in rat CA1 hippocampal interneurons by using the whole-cell voltage-clamp technique. Inhibition of the choline-induced current was less for 11a-11c than for the methylpiperidinium iodides 12a-12c and depended on the length of the aliphatic chain. Those compounds showing strong effects were studied further using molecular docking and molecular dynamics simulations. The strongest and non-voltage depen